-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Lisata Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
- Lisata Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$4.61M, a 14.1% increase year-over-year.
- Lisata Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$20M, a 4.1% increase year-over-year.
- Lisata Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$20M, a 4.1% increase from 2023.
- Lisata Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$20.8M, a 61.6% increase from 2022.
- Lisata Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$54.2M, a 97.4% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)